From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...
Black Mesa announces funding from the Advanced Research Projects Agency for Health (ARPA-H) to develop a Good AI ...
CAMBRIDGE, Mass., February 12, 2026 - Insilico Medicine (3696.HK), a clinical-stage, generative AI-driven drug discovery company, today announced the launch of a new interactive webpage highlighting ...
ADCs combine antibodies with drug payloads for targeted therapy, but complex manufacturing requires monitoring CQAs across multiple entities.
While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in ...
Experts have known for some time that Alzheimer’s disease involves the build-up of toxic protein fragments in the brain.
Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.
Whether a smartphone battery lasts longer or a new drug can be developed to treat incurable diseases depends on how stably the atoms constituting the material are bonded. The core of 'molecular design ...
Polymer micelles are tiny, self-assembled particles that are revolutionizing the landscape of drug delivery and nanomedicine. They form when polymer chains containing both hydrophilic and hydrophobic ...
AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results